BACKGROUND: Genetic variants influencing lung function in children and adults may ultimately lead to the development of chronic obstructive pulmonary disease (COPD), particularly in high-risk groups. METHODS: We tested for an association between single-nucleotide polymorphisms (SNPs) in the gene encoding matrix metalloproteinase 12 (MMP12) and a measure of lung function (prebronchodilator forced expiratory volume in 1 second [FEV(1)]) in more than 8300 subjects in seven cohorts that included children and adults. Within the Normative Aging Study (NAS), a cohort of initially healthy adult men, we tested for an association between SNPs that were associated with FEV(1) and the time to the onset of COPD. We then examined the relationship between MMP12 SNPs and COPD in two cohorts of adults with COPD or at risk for COPD. RESULTS: The minor allele (G) of a functional variant in the promoter region of MMP12 (rs2276109 [-82A-->G]) was positively associated with FEV(1) in a combined analysis of children with asthma and adult former and current smokers in all cohorts (P=2x10(-6)). This allele was also associated with a reduced risk of the onset of COPD in the NAS cohort (hazard ratio, 0.65; 95% confidence interval [CI], 0.46 to 0.92; P=0.02) and with a reduced risk of COPD in a cohort of smokers (odds ratio, 0.63; 95% CI, 0.45 to 0.88; P=0.005) and among participants in a family-based study of early-onset COPD (P=0.006). CONCLUSIONS: The minor allele of a SNP in MMP12 (rs2276109) is associated with a positive effect on lung function in children with asthma and in adults who smoke. This allele is also associated with a reduced risk of COPD in adult smokers. 2009 Massachusetts Medical Society
BACKGROUND: Genetic variants influencing lung function in children and adults may ultimately lead to the development of chronic obstructive pulmonary disease (COPD), particularly in high-risk groups. METHODS: We tested for an association between single-nucleotide polymorphisms (SNPs) in the gene encoding matrix metalloproteinase 12 (MMP12) and a measure of lung function (prebronchodilator forced expiratory volume in 1 second [FEV(1)]) in more than 8300 subjects in seven cohorts that included children and adults. Within the Normative Aging Study (NAS), a cohort of initially healthy adult men, we tested for an association between SNPs that were associated with FEV(1) and the time to the onset of COPD. We then examined the relationship between MMP12 SNPs and COPD in two cohorts of adults with COPD or at risk for COPD. RESULTS: The minor allele (G) of a functional variant in the promoter region of MMP12 (rs2276109 [-82A-->G]) was positively associated with FEV(1) in a combined analysis of children with asthma and adult former and current smokers in all cohorts (P=2x10(-6)). This allele was also associated with a reduced risk of the onset of COPD in the NAS cohort (hazard ratio, 0.65; 95% confidence interval [CI], 0.46 to 0.92; P=0.02) and with a reduced risk of COPD in a cohort of smokers (odds ratio, 0.63; 95% CI, 0.45 to 0.88; P=0.005) and among participants in a family-based study of early-onset COPD (P=0.006). CONCLUSIONS: The minor allele of a SNP in MMP12 (rs2276109) is associated with a positive effect on lung function in children with asthma and in adults who smoke. This allele is also associated with a reduced risk of COPD in adult smokers. 2009 Massachusetts Medical Society
Authors: S Jormsjö; S Ye; J Moritz; D H Walter; S Dimmeler; A M Zeiher; A Henney; A Hamsten; P Eriksson Journal: Circ Res Date: 2000-05-12 Impact factor: 17.367
Authors: M H Grol; J Gerritsen; J M Vonk; J P Schouten; G H Koëter; B Rijcken; D S Postma Journal: Am J Respir Crit Care Med Date: 1999-12 Impact factor: 21.405
Authors: Prescott G Woodruff; Laura L Koth; Yee Hwa Yang; Madeleine W Rodriguez; Silvio Favoreto; Gregory M Dolganov; Agnes C Paquet; David J Erle Journal: Am J Respir Crit Care Med Date: 2005-09-15 Impact factor: 21.405
Authors: Ladina Joos; Jian-Qing He; Megan B Shepherdson; John E Connett; Nicholas R Anthonisen; Peter D Paré; Andrew J Sandford Journal: Hum Mol Genet Date: 2002-03-01 Impact factor: 6.150
Authors: E K Silverman; H A Chapman; J M Drazen; S T Weiss; B Rosner; E J Campbell; W J O'DONNELL; J J Reilly; L Ginns; S Mentzer; J Wain; F E Speizer Journal: Am J Respir Crit Care Med Date: 1998-06 Impact factor: 21.405
Authors: A McGarry Houghton; Pablo A Quintero; David L Perkins; Dale K Kobayashi; Diane G Kelley; Luiz A Marconcini; Robert P Mecham; Robert M Senior; Steven D Shapiro Journal: J Clin Invest Date: 2006-02-09 Impact factor: 14.808
Authors: Guillaume Lettre; Anne U Jackson; Christian Gieger; Fredrick R Schumacher; Sonja I Berndt; Serena Sanna; Susana Eyheramendy; Benjamin F Voight; Johannah L Butler; Candace Guiducci; Thomas Illig; Rachel Hackett; Iris M Heid; Kevin B Jacobs; Valeriya Lyssenko; Manuela Uda; Michael Boehnke; Stephen J Chanock; Leif C Groop; Frank B Hu; Bo Isomaa; Peter Kraft; Leena Peltonen; Veikko Salomaa; David Schlessinger; David J Hunter; Richard B Hayes; Gonçalo R Abecasis; H-Erich Wichmann; Karen L Mohlke; Joel N Hirschhorn Journal: Nat Genet Date: 2008-04-06 Impact factor: 38.330
Authors: Alireza Sadeghnejad; Jill A Ohar; Siqun L Zheng; David A Sterling; Gregory A Hawkins; Deborah A Meyers; Eugene R Bleecker Journal: Respir Res Date: 2009-03-12
Authors: Robert A Philibert; Rory A Sears; Linda S Powers; Emma Nash; Thomas Bair; Alicia K Gerke; Ihab Hassan; Christie P Thomas; Thomas J Gross; Martha M Monick Journal: J Leukoc Biol Date: 2012-03-16 Impact factor: 4.962
Authors: Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich Journal: Thorax Date: 2017-06-21 Impact factor: 9.139